Business Wire

Yokogawa Establishes Sustainability Goals for the Year 2050

Del

Yokogawa Electric Corporation (TOKYO:6841) announces that it has developed sustainability goals for the year 2050 that will guide its efforts to make the world a better place for future generations.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170806005002/en/

Yokogawa's sustainability goals: "Three goals" (Graphic: Yokogawa Electric Corporation)

Yokogawa's sustainability goals: "Three goals" (Graphic: Yokogawa Electric Corporation)

Yokogawa’s efforts to achieve a sustainable society are in keeping with the Paris Agreement, which was adopted in 2015 by the 21st Framework Convention on Climate Change (COP21) to provide a basis for global efforts to tackle issues related to climate change. The agreement calls for the achievement of net-zero greenhouse gas emissions by the second half of this century. Also in 2015, the UN adopted the 2030 Agenda for Sustainable Development centering on the Sustainable Development Goals (SDGs). Through these initiatives, a global consensus is developing on how to address these issues, and the direction that companies should take is becoming clear.

Yokogawa’s efforts to achieve sustainability and build a brighter future for all are based on the company’s corporate philosophy, which states: “As a company, our goal is to contribute to society through broad-ranging activities in the areas of measurement, control, and information. Individually, we aim to combine good citizenship with the courage to innovate.” To ensure a flexible response to environmental and technology changes and guide its long-term efforts to address social issues, Yokogawa is committing itself to the achievement of goals that are based on a vision of where our society should be by the year 2050. Through the selection of products and solutions and the formulation of medium-term business plans and the like that are based on environmental, economic, and societal considerations, Yokogawa will carry out the detailed tasks needed to achieve these goals.

Commenting on this initiative, Takashi Nishijima, Yokogawa President and CEO, says: “Companies have a growing responsibility to respond to issues such as population growth and the rising use of fossil fuels that are addressed in the Paris Agreement and the SDGs. Yokogawa provides solutions that improve the stability, efficiency, and safety of operations at industrial plants and other infrastructure facilities by, for example, speeding up processes, reducing workloads, and saving energy. Yokogawa needs to work harder to broaden its solutions so that it can address other issues that impact our society. Yokogawa will establish key performance indicators (KPIs) to evaluate on a medium-term basis the achievement of its sustainability goals, and will continue to create new value through co-innovation with its customers and partners.

Statement on Yokogawa’s aspiration for sustainability

Yokogawa will work to achieve net-zero emissions, make a transition to a circular economy, and ensure the well-being of all by 2050, thus making the world a better place for future generations.

We will undergo the necessary transformation to achieve these goals by 1. becoming more adaptable and resilient, 2. evolving our businesses to engage in regenerative value creation, and 3. promoting co-innovation with our stakeholders.

 

Yokogawa’s sustainability goals: “Three goals”

Environmental:      

Achieve net-zero emissions

Economic:

Make transition to circular economy

Social:

Ensure well-being

 

Achieve net-zero emissions; stopping climate change
Climate change is an urgent issue that requires a global response. We aim for net-zero emissions, which means that the greenhouse gas concentrations in the atmosphere do not rise due to the balance of emissions and the absorption of greenhouse gases, which can be accomplished through the introduction of renewable energy and efficient use of energy. We are also working to reduce the impact of natural disasters and respond to biodiversity issues.

Make the transition to a circular economy; circulation of resources and efficiency
The transformation from a one-way economy based on the take, make, and dispose model to an economy where resources are circulated without waste, and the transition to businesses that emphasize services, are under way. We aim to realize a social framework and ecosystem in which various resources are circulated without waste and assets are utilized effectively. We also are contributing to the efficient use of water resources and the supply of safe drinking water.

Ensure well-being; quality life for all
With the aim of achieving the physical, mental, and social well-being described in the 2030 Agenda for Sustainable Development adopted by the United Nations in 2015, we support people's health and prosperity through the achievement of safe and comfortable workplaces and our pursuits in such areas as the life sciences and drug discovery. We promote human resource development and employment creation in local communities, and diversity and inclusion.

Yokogawa sustainability policies: www.yokogawa.com/csr/policy

About Yokogawa
Yokogawa's global network of 113 companies spans 60 countries. Founded in 1915, the US$3.5 billion company engages in cutting-edge research and innovation. Yokogawa is active in the industrial automation and control (IA), test and measurement, and aviation and other businesses segments. The IA segment plays a vital role in a wide range of industries including oil, chemicals, natural gas, power, iron and steel, pulp and paper, pharmaceuticals, and food. Targeting this segment, Yokogawa helps companies maximize their profits by offering a wide range of highly reliable products and working with the subsidiary KBC Advanced Technologies to provide premium solutions and services. For more information about Yokogawa, please visit www.yokogawa.com.

Contact information

Yokogawa Electric Corporation
Public Relations, Integrated Communications Center
Yokogawa-pr@cs.jp.yokogawa.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00Pressemelding

Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba

ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11Pressemelding

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with

Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo

Chugai Presents Results of Two Pivotal Phase lll Studies for its Bispecific Antibody HEMLIBRA® at WFH 201821.5.2018 09:44Pressemelding

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced that full results from HAVEN 3 study (NCT02847637) and HAVEN 4 study (NCT03020160) evaluating Chugai’s hemophilia A treatment HEMLIBRA® [generic name: emicizumab (genetical recombination)] are being presented at the World Federation of Hemophilia 2018 World Congress held in Glasgow, Scotland from May 20 to 24. HAVEN 3 study is conducted in people with hemophilia A without inhibitors, and HAVEN 4 study is conducted in people with hemophilia A with or without inhibitors. Results from both studies will be presented as late-breaking abstracts. “The results from HAVEN 3 study demonstrate that HEMLIBRA, which was created with Chugai’s proprietary antibody engineering technologies, can reduce the bleeding risk in people with hemophilia A without inhibitors. The intra-patient comparison in this study also shows a statistically significant reduction in bleeding by HEMLIBRA prophylaxis compared to factor VIII therapy, the current stand

STATS Unveils STATS GPS, the Most Advanced Technology for Athlete Monitoring21.5.2018 07:00Pressemelding

Today, STATS, the worldwide leader in sports data and intelligence, unveiled STATS GPS, an innovative system that uses a revolutionary 50-Hz sampling frequency to provide the most advanced real-time GPS technology available. STATS GPS allows teams to monitor player performance with customizable metrics like accelerations/decelerations, energy expenditure, count of zone entries, and time, distance and power thresholds. The innovative solution uses real 50-Hz sampling frequency and allows practitioners to monitor up to 100 players in real-time and post session with over 300 GPS, IMU and HR derived metrics. Embedded in the GPS vests are textile heart-rate sensors, making STATS GPS the most advanced technology on the market. “Teams and conditioning coaches need the latest technology to ensure players stay at peak health and fitness during long seasons,” said Ryan Paterson, Chief Global Officer at STATS. “With STATS GPS’ new 50-Hz technology, teams can instantly get performance information,

MATCHESFASHION.COM Has Another Strong Year of Growth Driven by International Expansion21.5.2018 06:00Pressemelding

MATCHESFASHION.COM, the global luxury-shopping destination for men and women, experienced another strong year of growth in 2017 with revenue up 44% year on year. EBITDA was up 34% driven by international growth. Technology has enabled the business to scale internationally, enhance the customer experience and power social innovation such as the launch of The Style Daily and The Style Social, delivering unique daily content to users. The success of the app last year led to more than half of online business being conducted via mobile. 2017 also saw the launch of two local-language websites in French and Korean and, in October, funds advised by Apax Partners acquired a majority stake in the company. Building on this momentum in 2018, MATCHESFASHION.COM increased their physical footprint; the Hong Kong office has tripled in size and in April they launched a state-of-the-art creative studio in East London. In the summer a new 500,000 square ft global distribution centre will open in London f